![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-catechin | multiple interactions | ISO | CRYZL1 (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of CRYZL1 mRNA | CTD | PMID:24763279 | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | CRYZL1 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CRYZL1 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | multiple interactions | ISO | Cryzl1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CRYZL1 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | ISO | Cryzl1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CRYZL1 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cryzl1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CRYZL1 mRNA | CTD | PMID:21570461 | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:23196670 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Cryzl1 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of CRYZL1 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CRYZL1 mRNA | CTD | PMID:36041667 | aflatoxin B1 | increases methylation | ISO | CRYZL1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of CRYZL1 gene | CTD | PMID:27153756 | antirheumatic drug | increases expression | ISO | CRYZL1 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of CRYZL1 mRNA | CTD | PMID:24449571 | arsenite(3-) | multiple interactions | ISO | CRYZL1 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to CRYZL1 mRNA] | CTD | PMID:32406909 | atrazine | increases expression | ISO | CRYZL1 (Homo sapiens) | 6480464 | Atrazine results in increased expression of CRYZL1 mRNA | CTD | PMID:22378314 | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of CRYZL1 gene | CTD | PMID:28931070 | benzo[a]pyrene | increases expression | ISO | Cryzl1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CRYZL1 mRNA | CTD | PMID:22228805 | bisphenol A | increases expression | ISO | Cryzl1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of CRYZL1 mRNA | CTD | PMID:26063408 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CRYZL1 mRNA | CTD | PMID:36041667 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CRYZL1 mRNA | CTD | PMID:25181051 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CRYZL1 mRNA | CTD | PMID:36041667 | calyculin a | increases expression | ISO | Cryzl1 (Mus musculus) | 6480464 | calyculin A results in increased expression of CRYZL1 mRNA | CTD | PMID:25270620 | CGP 52608 | multiple interactions | ISO | CRYZL1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CRYZL1 gene] | CTD | PMID:28238834 | chlorpyrifos | increases expression | ISO | Cryzl1 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of CRYZL1 mRNA | CTD | PMID:37019170 | choline | multiple interactions | ISO | Cryzl1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CRYZL1 gene | CTD | PMID:20938992 | copper(II) sulfate | decreases expression | ISO | CRYZL1 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of CRYZL1 mRNA | CTD | PMID:19549813 | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of CRYZL1 mRNA | CTD | PMID:23640034 | dicrotophos | decreases expression | ISO | CRYZL1 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of CRYZL1 mRNA | CTD | PMID:28302478 | doxorubicin | decreases expression | ISO | CRYZL1 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of CRYZL1 mRNA | CTD | PMID:29803840 | epoxiconazole | decreases expression | ISO | Cryzl1 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of CRYZL1 mRNA | CTD | PMID:35436446 | ethanol | affects expression | ISO | Cryzl1 (Mus musculus) | 6480464 | Ethanol affects the expression of CRYZL1 mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | ISO | Cryzl1 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | folic acid | decreases expression | ISO | Cryzl1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of CRYZL1 mRNA | CTD | PMID:25629700 | ivermectin | increases expression | ISO | CRYZL1 (Homo sapiens) | 6480464 | Ivermectin results in increased expression of CRYZL1 protein | CTD | PMID:32959892 | L-methionine | multiple interactions | ISO | Cryzl1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CRYZL1 gene | CTD | PMID:20938992 | lead diacetate | increases expression | ISO | Cryzl1 (Mus musculus) | 6480464 | lead acetate results in increased expression of CRYZL1 mRNA | CTD | PMID:25270620 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of CRYZL1 gene | CTD | PMID:35440735 | methyl methanesulfonate | increases expression | ISO | CRYZL1 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of CRYZL1 mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | ISO | CRYZL1 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of CRYZL1 mRNA | CTD | PMID:28001369 | methylmercury chloride | increases expression | ISO | CRYZL1 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of CRYZL1 mRNA | CTD | PMID:28001369 | methylparaben | increases expression | ISO | CRYZL1 (Homo sapiens) | 6480464 | methylparaben results in increased expression of CRYZL1 mRNA | CTD | PMID:31745603 | N-methyl-4-phenylpyridinium | increases expression | ISO | Cryzl1 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of CRYZL1 mRNA | CTD | PMID:22776087 | ozone | multiple interactions | ISO | CRYZL1 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of CRYZL1 mRNA | CTD | PMID:35430440 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CRYZL1 mRNA | CTD | PMID:33387578 | pirinixic acid | increases expression | ISO | Cryzl1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of CRYZL1 mRNA | CTD | PMID:25270620 | potassium chromate | decreases expression | ISO | CRYZL1 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of CRYZL1 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | CRYZL1 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CRYZL1 mRNA | CTD | PMID:22079256 | quercetin | decreases expression | ISO | CRYZL1 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of CRYZL1 mRNA | CTD | PMID:21632981 | quercitrin | decreases expression | ISO | CRYZL1 (Homo sapiens) | 6480464 | quercitrin results in decreased expression of CRYZL1 mRNA | CTD | PMID:25193878 | resveratrol | increases expression | ISO | Cryzl1 (Mus musculus) | 6480464 | resveratrol results in increased expression of CRYZL1 mRNA | CTD | PMID:22610192 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of CRYZL1 mRNA | CTD | PMID:19013527 | Soman | decreases expression | EXP | | 6480464 | Soman results in decreased expression of CRYZL1 mRNA | CTD | PMID:19281266 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of CRYZL1 mRNA | CTD | PMID:34492290 | Tributyltin oxide | increases expression | ISO | Cryzl1 (Mus musculus) | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of CRYZL1 mRNA | CTD | PMID:25270620 | triptonide | decreases expression | ISO | Cryzl1 (Mus musculus) | 6480464 | triptonide results in decreased expression of CRYZL1 mRNA | CTD | PMID:33045310 | trovafloxacin | decreases expression | ISO | Cryzl1 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of CRYZL1 mRNA | CTD | PMID:35537566 | valproic acid | increases expression | ISO | CRYZL1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CRYZL1 mRNA | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | CRYZL1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CRYZL1 mRNA | CTD | PMID:23179753 | valproic acid | affects expression | ISO | CRYZL1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CRYZL1 mRNA | CTD | PMID:25979313 | vorinostat | increases expression | ISO | CRYZL1 (Homo sapiens) | 6480464 | vorinostat results in increased expression of CRYZL1 mRNA | CTD | PMID:27188386 | |